Swenson DL - Search Results

1

NKp30-dependent cytolysis of filovirus-infected human dendritic cells.

Fuller CL, Ruthel G, Warfield KL, Swenson DL, Bosio CM, Aman MJ, Bavari S. Fuller CL, et al. Among authors: swenson dl. Cell Microbiol. 2007 Apr;9(4):962-76. doi: 10.1111/j.1462-5822.2006.00844.x. Cell Microbiol. 2007. PMID: 17381429

2

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.

Swenson DL, Warfield KL, Kuehl K, Larsen T, Hevey MC, Schmaljohn A, Bavari S, Aman MJ. Swenson DL, et al. FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):27-31. doi: 10.1016/S0928-8244(03)00273-6. FEMS Immunol Med Microbiol. 2004. PMID: 14734183 Free article.

3

Role of natural killer cells in innate protection against lethal ebola virus infection.

Warfield KL, Perkins JG, Swenson DL, Deal EM, Bosio CM, Aman MJ, Yokoyama WM, Young HA, Bavari S. Warfield KL, et al. Among authors: swenson dl. J Exp Med. 2004 Jul 19;200(2):169-79. doi: 10.1084/jem.20032141. Epub 2004 Jul 12. J Exp Med. 2004. PMID: 15249592 Free PMC article.

4

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.

Warfield KL, Posten NA, Swenson DL, Olinger GG, Esposito D, Gillette WK, Hopkins RF, Costantino J, Panchal RG, Hartley JL, Aman MJ, Bavari S. Warfield KL, et al. Among authors: swenson dl. J Infect Dis. 2007 Nov 15;196 Suppl 2:S421-9. doi: 10.1086/520612. J Infect Dis. 2007. PMID: 17940979

5

Filovirus-like particles as vaccines and discovery tools.

Warfield KL, Swenson DL, Demmin G, Bavari S. Warfield KL, et al. Among authors: swenson dl. Expert Rev Vaccines. 2005 Jun;4(3):429-40. doi: 10.1586/14760584.4.3.429. Expert Rev Vaccines. 2005. PMID: 16026254 Free article. Review.

6

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.

Warfield KL, Swenson DL, Negley DL, Schmaljohn AL, Aman MJ, Bavari S. Warfield KL, et al. Among authors: swenson dl. Vaccine. 2004 Sep 3;22(25-26):3495-502. doi: 10.1016/j.vaccine.2004.01.063. Vaccine. 2004. PMID: 15308377

7

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.

Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S. Swenson DL, et al. Vaccine. 2005 Apr 27;23(23):3033-42. doi: 10.1016/j.vaccine.2004.11.070. Vaccine. 2005. PMID: 15811650

8

Analysis of Ebola virus and VLP release using an immunocapture assay.

Kallstrom G, Warfield KL, Swenson DL, Mort S, Panchal RG, Ruthel G, Bavari S, Aman MJ. Kallstrom G, et al. Among authors: swenson dl. J Virol Methods. 2005 Jul;127(1):1-9. doi: 10.1016/j.jviromet.2005.02.015. Epub 2005 Apr 25. J Virol Methods. 2005. PMID: 15893559

9

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.

Warfield KL, Olinger G, Deal EM, Swenson DL, Bailey M, Negley DL, Hart MK, Bavari S. Warfield KL, et al. Among authors: swenson dl. J Immunol. 2005 Jul 15;175(2):1184-91. doi: 10.4049/jimmunol.175.2.1184. J Immunol. 2005. PMID: 16002721

10

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iversen PL, Bavari S. Warfield KL, et al. Among authors: swenson dl. PLoS Pathog. 2006 Jan;2(1):e1. doi: 10.1371/journal.ppat.0020001. Epub 2006 Jan 13. PLoS Pathog. 2006. PMID: 16415982 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters